Market Research Report
Global Sleep Apnea Devices Market - 2021-2028
|Global Sleep Apnea Devices Market - 2021-2028|
Published: December 1, 2021
Content info: 180 Pages
Delivery time: 2 business days
The global sleep apnea devicesmarket size was worth US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, growing at a CAGR of YY % during the forecast period (2021-2028).
Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts. The goal of sleep apnea treatment is to open the airway so patient can breathe better at night. Sleep apnea devices can help that happen. Among the most common options are CPAP machines, Facial Interfaces, and Adaptive servo-ventilators and others.
The global sleep apnea devicesmarket growth is driven by theincreasing incidences of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increasing awareness among the patient population in developing countries.
Ongoing technological advancementsis expected to drive the growth in the forecast period
The development of new technologies for the treatment and diagnosis of the disease is driving market growth. Moreover, new alternatives to CPAP equipment such as nasal and oral equipment are developed for patients with low CPAP tolerance.For instance, In February 2021, GoPAPFree, a homecare oral devices manufacturer for OSA, launched O2 Vent Optima to serve as an effective and more convenient CPAP alternative. This device increases sleep apnea therapy response by 40.0%. In February 2020, Fisher and Paykel launched F&P Evora with CapFit headgear, a compact nasal mask for treating sleep apnea. The company launched this product in the markets of New Zealand, Europe, Australia, and Canada.
With the rising technological advancements and product innovations, mid-size and small-scale companies are increasing their market presence by introducing new devices into the market at competitive prices. Companies, like Resmed, Fisher & Paykel Healthcare Limited, and Invacare Corporation, hold substantial shares in the market.For instance, in 2019, ResMed launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the U.S. with a newly designed nasal cradle cushion that sits just under the wearer's nose.The trend is shifting towards mHealth apps for remote monitoring of sleep, enhancement of patient outcomes, and real-time screening of patient data. Detection of symptoms of sleep apnea are done by the built-in sensor technology available in smartphones. These factors are driving the market growth in the forecast period.
The high cost of CPAP machines is likely to hamper the market growth
A CPAP machine's cost can range anywhere from $250 to $1,000 or more, with prices generally rising for machines with more advanced features. Most CPAP machines fall in the $500 to $800 range. However. BiPAP (Bilevel Positive Airway Pressure) machines are more complex and tend to cost more as a result. Most BiPAP machines cost $1,000 to $3,000, but some can run as high as $6,000. These prices don't include accessories. Additional features can increase the cost of standard CPAP machines. For instance, a machine with a heated humidifier costs more than a machine without one. CPAP air filters can cost anywhere from $5 to $30 each, depending on the type of machine. Headgear and mask set generally cost $100 or more. Smaller pieces that need replacing more often, such as mask cushions, range from $20 to $100. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy creates a huge hurdle for patients. These factors will hamper the market in the forecast period.
The COVID-19 pandemic is expected to have a positive impact on the sleep apnea devices market. According to 'Strausz S, Kiiskinen T, Broberg M, et al., sleep apnoea a risk factor for severe COVID-19,' published in January 2021 in the BMJ Open Respiratory Research, patients with obstructive sleep apnea (OSA) had a 2.93 times higher risk to be hospitalized when affected by COVID-19 than non-OSA individuals. The study also suggested that in the assessment of patients who were suspected or confirmed with COVID-19 infection, obstructive sleep apnea should be recognized as one of the comorbidity risks factors for developing a severe form of the disease. According to another study published in September 2020 in Springer titled 'Obstructive Sleep Apnea and Risk of COVID-19 Infection, Hospitalization and Respiratory Failure', the patients in the study with obstructive sleep apnea experienced around an eight-times greater risk for COVID-19 infection compared to a similar-aged population receiving care in a major, racially, and socio-economically diverse healthcare system. In patients who contracted COVID-19 infection, obstructive sleep apnea was associated with an increased risk of hospitalization, with approximately double the risk of developing respiratory failure. Thus, due to the higher risk of developing obstructive sleep apnea, there is likely to be a demand for sleep apnea devices that helps to alleviate the disorder, which is expected to affect market development positively.
Thepulse oximeterssegmentis expected to hold the largest share in this market segment
Pulse oximeters are used extensively in the measurement of blood hemoglobin oxygen saturation. They are used to measure blood hemoglobin oxygen saturation continuously over time in a relatively non-invasive way. Due to their convenience, they have become an almost ubiquitous instrument in hospitals and healthcare institutions. The application of pulse oximetry to investigate and diagnose obstructive sleep apnea in adults and children consists of different practices. When pulse oximeters are used as a part of an overnight polysomnogram (PSG), the patterns in the oximetry data can be interpreted in the context of events in other physiological channels, potentially allowing detailed characterization of the pathophysiology.
Medtronic manufactures a pulse oximeter called Nellcor portable SpO2 patient monitoring system, PM10N. This device is ideal for instant checks and continuous monitoring in various healthcare and also home use settings. Its ergonomic shape and simple design make it intuitive to use and simple to operate. The availability of these types of devices will help with the market growth.
North America region holds the largest market share of global sleep apnea devices market
North America currently dominates the market for sleep apnea devices, and it is expected to continue during the forecast period. The region is expected to see robust growth now and in the future due to the high incidence of sleep-disordered breathing (SDB) and the rising aging population in the region. The United States holds the majority of the market in North America. According to the American Sleep Association, in 2018, approximately 50-70 million adult population in the United States were found to have a sleep disorder, 37.9% were reported to be falling asleep during the day unintentionally, 48% were reported to have snoring disorders, and 4.7% were reported to be nodding off while driving. Approximately 25 million adults in the United States have obstructive sleep apnea. Insomnia is the most common specific sleep disorder, with short-term issues reported by about 30% of adults and chronic insomnia by 10%.
According to Sleep Zone, about 22 million Americans suffer from moderate to severe sleep apnea, out of which approximately 3-7% of men and 2-5% of women were found to have had sleep apnea in 2018 in the United States.
The global sleep apnea devices market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market includePhilips Healthcare, Cadwell Laboratories Inc., Fisher & Paykel Healthcare Limited, Natus Medical Incorporated, ResMed, Nihon Kohden Corporation, Invacare Corporation, keepMED Ltd., Sleep score, BMC Medical CO., Ltd, ImThera Medical Inc. and others.The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Sleep Apnea Devices globally. For instance,In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy in the US through GoPAPfree.
Overview:ResMed develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases.The company operates in two segments, Sleep and Respiratory Care,and Software as a Service. The company's cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Their comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.
Product Portfolio: It includes products like Acumen 7, Lotus Auto CPAP, Floton, AirSense 11, AirCurve 10 VAuto, AirSense 10 Series.
Acumen 7- It is a sleep diagnostic device specifically designed for use in the home away from clinical environments. Acumen 7 can record up to 100 hours of relevant physiological data over up to 8 channels.
Key Developments:In June 2021, ResMed the parent company of Curative Medical Inc launched AirSense 11 in the U.S.
Visualize the composition of the sleep apnea devices market segmentation by device type, end-user, and region highlighting the key commercial assets and players.
Identify commercial opportunities in sleep apnea devices market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of sleep apnea devices market - level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players.
The global sleep apnea devices market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Global Sleep Apnea Devices Market- By Device Type
Positive Airway Pressure (PAP) Devices
Auto-Titrating Positive Airway Pressure (APAP)
Bi-level Positive Airway Pressure (BiPAP)
Continuous Positive Airway Pressure (CPAP)
Polysomnography (PSG) Device
Single-channel Screening Devices (Pulse Oximeter)
Global Sleep Apnea Devices Market - By End-User
Sleep Laboratories and Hospitals
Home Care Settings/Individuals
Global Sleep Apnea Devices Market - By Region
Middle East & Africa
LIST NOT EXHAUSTIVE